Japanese Red Cross Nagasaki Genbaku Hospital

Nagasaki 8528511

0 studies enrolling now · 7 studies all time

What they study most

B-cell Non-Hodgkin Lymphoma (B-NHL), Branch Retinal Vein Occlusion, Central Retinal Vein Occlusion, Chronic Kidney Disease, Diabetic Macular Edema, Hemi-retinal Vein Occlusion, Multiple Myeloma, Neovascular Age-Related Macular Degeneration, Neovascular Age-related Macular Degeneration, Retinal Vein Occlusion, Type 2 Diabetes Mellitus, Wet Macular Degeneration

Studies at this site

• A Study to Assess the Anti-Tumor Activity and Safety of Odronextamab in Adult Patients With B-cell Non-Hodgkin Lymphoma Who Have Been Previously Treated With Other Cancer Therapies — Running, not enrolling
• A Real-World Study to Gain Clinical Insights Into Roche Ophthalmology Products — Running, not enrolling
• A Study to Determine Dose, Safety, Tolerability and Efficacy of CC-220 Monotherapy, and in Combination With Other Treatments in Subjects With Multiple Myeloma — Running, not enrolling
• A Study to Evaluate the Long-Term Safety and Tolerability of Faricimab in Participants With Neovascular Age-Related Macular Degeneration — Completed
• Study of the Effects of High Dose Aflibercept Injected Into the Eye of Patients With an Age-related Disorder That Causes Loss of Vision Due to Growth of Abnormal Blood Vessels at the Back of the Eye — Completed
• A Study to Evaluate the Efficacy and Safety of Faricimab in Participants With Neovascular Age-Related Macular Degeneration (TENAYA) — Completed
• An add-on Study to the FIGARO-DKD Study Called FIGARO-BM to Learn About the Link Between Biomarkers (Substances in the Blood Used as Indicators of Biological Processes, Disease Processes or Responses to Medication) and Finerenone in FIGARO-DKD Participants — Completed